CAMP
CAMP4 Therapeutics Corporation
There isn't enough reported data to score CAMP yet.
OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CAMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Weak |
CAMP's profitability, cash flow and balance sheet are currently under pressure. There isn't enough data to rate its revenue.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAMP PE Valuation
CAMP has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CAMP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAMP's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
CAMP Earnings Per Share
CAMP lost $2.13 per share over the past year, a bigger loss than the year before.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over CAMP in the latest year-over-year earnings comparison.
CAMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | +139% |
| Q2 2026 | $1.8M | +19% |
| Q1 2026 | $1.3M | +51% |
| Q3 2023 | $350K | -100% |
| Q2 2023 | $70.9M | +9.5% |
| Q1 2023 | $78.5M | +15% |
| Q4 2022 | $78.9M | +15% |
| Q3 2022 | $72.8M | -7.8% |
CAMP's revenue is recovering but still below its 2020 peak: $2M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -739% | +978 points |
| Q2 2026 | -752% | +118 points |
| Q1 2026 | -1010% | +517 points |
| Q4 2025 | -3671% | N/A |
| Q3 2025 | -1717% | N/A |
| Q2 2025 | -870% | N/A |
| Q1 2025 | -1527% | N/A |
| Q3 2023 | -3525% | -3518 points |
CAMP's operating margin was −739% last quarter, up 978 points from the same quarter a year ago.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over CAMP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over CAMP on profitability, with a higher operating margin.
CAMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.9M | +$2.3M |
| Q2 2026 | -$12.8M | -$2.5M |
| Q1 2026 | -$11M | +$3.6M |
| Q4 2025 | $6.3M | +$17.8M |
| Q2 2025 | -$10.3M | +$3.3M |
| Q1 2025 | -$14.6M | -$3.4M |
| Q4 2024 | -$11.6M | +$475K |
| Q2 2024 | -$13.6M | -$10.5M |
CAMP has burned cash in most quarters: −$26M over the past year, against −$48M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over CAMP on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAMP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +21M shares |
| 1 year | +292% | +58.8M shares |
| 3 years | +119% | +42.9M shares |
CAMP has 79M diluted shares, up 292% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over CAMP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CAMP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 25.3x | High |
| Q2 2021 | 14.1x | High |
| Q1 2021 | 8.2x | High |
| Q4 2020 | 15.9x | High |
| Q3 2020 | 16.1x | High |
| Q2 2020 | 9.9x | High |
| Q1 2020 | 13.2x | High |
CAMP's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
CAMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 35.4 | Neutral |
CAMP's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
CAMP PE vs Healthcare Sector
CAMP has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
CAMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.78 | 8.2% above |
| 20 week MA | $4.03 | 1.5% above |
| 50 week MA | $4.39 | 6.8% below |
| 100 week MA | $3.75 | 9.1% above |
OSCR has stronger trend alignment. CAMP is above 3 of 4 weekly averages versus OSCR above 5 of 5.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR is in an uptrend: it's above all five of its weekly moving averages, and 106% above its 200-week average.
CAMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.7 | $5.43 | -49% |
| 2025 | $5.43 | $5.96 | +9.8% |
| 2026 YTD | $5.96 | $4.09 | -31% |
CAMP has finished lower in one of the last two years. It's down 31% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over CAMP on returns for 2026, with the stronger performance.